yourstate.us
Cal. Health and Safety Code § 123704

Cal. Health and Safety Code § 123704

California · California Health and Safety Code · Status: effective · Effective 1996-09-29

Get this as JSONEmbed this
Cite this
Citation
Cal. Health and Safety Code § 123704, California, version 1 as recorded 2026-07-25, yourstate.us, https://yourstate.us/provision/875680
Permanent ID
ys:prov:875680@1
SHA-256
5f8f33c8433a39d5af44e0ca3f823ac87bbef975f42ffecbdff8272600d0b601

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

The Infant Botulism Treatment and Prevention Unit shall provide all the following services: (a) Produce, or cause to have produced, and maintain, a supply of BIG sufficient to treat the expected number of annual cases of infant botulism in the United States, and to store, or arrange storage for, same. (b) Distribute BIG to patients suspected of having infant botulism or other forms of botulism in California and in the rest of the United States on appropriate medical indications. (c) Investigate ways to improve the treatment of infant botulism and related illness, including technical improvement of BIG, and implement them as appropriate. (d) Provide diagnostic laboratory services and medical and public health expertise about infant botulism and related illnesses to all physicians, hospitals, laboratories, and parents statewide. (e) Investigate all cases or suspected cases of infant botulism with both field and laboratory techniques as appropriate, in order to acquire the broadest data base for prevention and optimal treatment. (f) Develop and implement control measures for the prevention of infant botulism and related illnesses. (g) Share with other public health agencies the expertise gained in the development of BIG as it relates to other toxin-mediated infectious diseases of public health importance, and apply that expertise as appropriate. (h) Establish scientific collaborations with university, forensic, hospital, public health, pharmaceutical, and biotechnology institutions, as appropriate as determined by the unit, that have resources and expertise to contribute to the study, prevention, or treatment of infant botulism and related illnesses.